Author Archives: Bénédicte Huchet

Join the Molecular Imaging Workshop 2017

The second edition of the Molecular Imaging Workshop 2017 (MIW2017) will be held from 20th to 23rd November 2017 in San Sebastian, Spain. 

MIW 2017

Academic and industrial researchers are welcome to join the workshop. For instance an industrial forum is organized to exchange ideas and network. People can also submit abstracts to participate to the poster session.

Organized by CIC biomaGUNE, the workshop will cover topics related to molecular imaging. The MIW2017 is the opportunity to discuss molecular imaging applications to neurosciences and oncology. Do not miss the sessions dedicated to cardiovascular application, infection tracking and pneumology.

The PneumoNP project will also attend the event. Attendees will be updated of the latest results of the project.

Several invited speakers are already announced. Jesús Ruíz Cabello from the Complutense University of Madrid, Spain, will give a lecture on the “characterization of metabolic reprogramming in pulmonary hypertension”. Jason Holland will come from Zurich to discuss “PET radiotracers for imaging oncogenic signaling pathways”.
The full list of invited speakers is available on the MIW2017 website.

You can already submit your abstract for the MIW2017 and so until the 31st August 2017. All abstracts must be related to one of the following categories:

  • Oncology
  • Cardiology
  • Neurosciences
  • Infectious diseases and metabolism
  • Imaging technology, methodology and data analysis
  • Imaging probes
  • Pulmonology and respiratory
__________________________________________________________________
Follow the PneumoNP team from event to event
cropped-Logo_PneumoNP_Simple_PRINT-01.png

Join the Molecular Imaging Workshop 2017

The second edition of the Molecular Imaging Workshop 2017 (MIW2017) will be held from 20th to 23rd November 2017 in San Sebastian, ...
Read More
ETP Nanomedicine is the European Forum aiming at developping, supporting and promoting the field of nanotechnologies applied to medicine.
ETP Nanomedicine translates business, clinical interface, toxicology and characterisation, education and training, ethics and social impact to pursue its goal. Indeed, the organisation intent is to enable diagnostics and imaging, therapy and targeted delivery, and regenerative medicine.

Meet us at the ETPN2017 event

PneumoNP partners will attend the ETPNanomedicine event in Malaga, Spain from 17th to 19th October 2017. The European Technology Platform on Nanomedicine ...
Read More
FIGON Conference

Meet us at the FIGON Dutch Medicine Days

PneumoNP partners will attend FIGON Dutch Medicine Days in Ede, the Netherlands on 2nd and 3rd of October 2017. The ...
Read More

Meet us at the ETPN2017 event

PneumoNP partners will attend the ETPNanomedicine event in Malaga, Spain from 17th to 19th October 2017.

ETP Nanomedicine is the European Forum aiming at developping, supporting and promoting the field of nanotechnologies applied to medicine. Besides, ETP Nanomedicine translates business, clinical interface, toxicology and characterisation, education and training, ethics and social impact to pursue its goal.

The European Technology Platform on Nanomedicine organizes its 12th annual event in Spain. It is the occasion for expert in the nanomedicine field to discover new approached, to network, to prepare new projects and to brainstorm.

The coordinator of the PneumoNP project will attend ETPN 2017. She will present the most significant results of the PneumoNP project, that will end by the end of 2017.

Find all the necessary information related to the event on: etpn2017.eu.

__________________________________________________________________
Follow the PneumoNP team from event to event
cropped-Logo_PneumoNP_Simple_PRINT-01.png

Join the Molecular Imaging Workshop 2017

The second edition of the Molecular Imaging Workshop 2017 (MIW2017) will be held from 20th to 23rd November 2017 in San Sebastian, ...
Read More
ETP Nanomedicine is the European Forum aiming at developping, supporting and promoting the field of nanotechnologies applied to medicine.
ETP Nanomedicine translates business, clinical interface, toxicology and characterisation, education and training, ethics and social impact to pursue its goal. Indeed, the organisation intent is to enable diagnostics and imaging, therapy and targeted delivery, and regenerative medicine.

Meet us at the ETPN2017 event

PneumoNP partners will attend the ETPNanomedicine event in Malaga, Spain from 17th to 19th October 2017. The European Technology Platform on Nanomedicine ...
Read More
FIGON Conference

Meet us at the FIGON Dutch Medicine Days

PneumoNP partners will attend FIGON Dutch Medicine Days in Ede, the Netherlands on 2nd and 3rd of October 2017. The ...
Read More

 

Meet us at the FIGON Dutch Medicine Days

PneumoNP partners will attend FIGON Dutch Medicine Days in Ede, the Netherlands on 2nd and 3rd of October 2017.

FIGON Conference

The Dutch Medicines Days are the event for the Dutch industry, scientific institutes and governmental organizations to present their research, share new findings and strengthen their network.

Several PneumoNP partners attend FIGON 2017. They will present the most significant results of the PneumoNP project.

On Monday 23rd, Yvonne te Welscher, from Utrecht University, will give a presentation during the session: Immunopharmacology, Infections, and Inflammation. The session takes place in room CERISE from 14:30 to 16:30. Her presentation will covers “Delivery of nanotherapeutics containing antimicrobial peptides in the lung aiming to treat antibiotic-resistant Gram-negative pneumonia”.

Find all the necessary information related to the event on: www.figondmd.nl.

__________________________________________________________________
Follow the PneumoNP team from event to event
cropped-Logo_PneumoNP_Simple_PRINT-01.png

Join the Molecular Imaging Workshop 2017

The second edition of the Molecular Imaging Workshop 2017 (MIW2017) will be held from 20th to 23rd November 2017 in San Sebastian, ...
Read More
ETP Nanomedicine is the European Forum aiming at developping, supporting and promoting the field of nanotechnologies applied to medicine.
ETP Nanomedicine translates business, clinical interface, toxicology and characterisation, education and training, ethics and social impact to pursue its goal. Indeed, the organisation intent is to enable diagnostics and imaging, therapy and targeted delivery, and regenerative medicine.

Meet us at the ETPN2017 event

PneumoNP partners will attend the ETPNanomedicine event in Malaga, Spain from 17th to 19th October 2017. The European Technology Platform on Nanomedicine ...
Read More
FIGON Conference

Meet us at the FIGON Dutch Medicine Days

PneumoNP partners will attend FIGON Dutch Medicine Days in Ede, the Netherlands on 2nd and 3rd of October 2017. The ...
Read More

Antibiotic resistance: Hope may come from small biotech companies

Discover Adenium, a small biotech company from Denmark. It develops the molecule that may become the next generation of antibiotics.

Every antibiotic in use today is based on a discovery made more than 30 years ago”. This is a worriedly observation done by the Pew Trust Charity in 2016. Indeed, antibiotics become less and less efficient. And since the 80’s, no new mechanism to fight bacterial infections has been brought onto the market.

Major Classes of Antibiotics

Click to enlarge

Despite their investments and efforts, big pharma companies struggle to develop a new class of antibiotic drug. For the company supporting the initiative, developing a brand new drug is demanding. It requires to take risks, and enough flexibility to change plans with new approaches if needed. What if the solution comes from small biotech companies?

In the race against the rising antibiotic resistance, smaller research companies emerge. For instance, the Danish biotech company Adenium Biotech is committed to finding the next therapeutic mechanism. They explore the potential of a new group of antimicrobial peptides called Arenicin-3. Peptides of this group have the advantage to attack bacteria membranes in a novel way.

Arenicin3 3D model

AA139 peptide – ©AdeniumBiotech

In particular, one molecule of the Arenicin-3 group is very promising: the AA139 peptide. Indeed, it is not toxic to human tissues and seems to have high bacteria-killing activity, including bacteria that are resistant to currently available antibiotics. For these reasons, it was judged by Adenium as a good candidate for drug development.

In 2014, the Danish company joined the EU-funded PneumoNP project as the AA139 peptide was at an early preclinical stage. The European project was a good opportunity for Adenium to test AA139 and compare the peptide to other promising molecules. Now, Adenium has GMP produced AA139 and is progressing toward clinical development.

Also, the PneumoNP project explored an interesting area for AA139. The project team loaded the peptide in a shell made of a nanoparticle and results showed that AA139 retained its antimicrobial activity after encapsulation. Results of the related studies should be published soon.

Currently, only a few non-traditional antibiotics are under clinical development. There are probiotics, antibodies, and vaccines. Antimicrobial peptides build hope for a new class of novel antibiotics. At the end, the innovation might come from small biotech companies like Adenium.

__________________________________________________________________

Read more PneumoNP news

cropped-Logo_PneumoNP_Simple_PRINT-01.png

Join the Molecular Imaging Workshop 2017

The second edition of the Molecular Imaging Workshop 2017 (MIW2017) will be held from 20th to 23rd November 2017 in San Sebastian, ...
Read More
ETP Nanomedicine is the European Forum aiming at developping, supporting and promoting the field of nanotechnologies applied to medicine.
ETP Nanomedicine translates business, clinical interface, toxicology and characterisation, education and training, ethics and social impact to pursue its goal. Indeed, the organisation intent is to enable diagnostics and imaging, therapy and targeted delivery, and regenerative medicine.

Meet us at the ETPN2017 event

PneumoNP partners will attend the ETPNanomedicine event in Malaga, Spain from 17th to 19th October 2017. The European Technology Platform on ...
Read More
FIGON Conference

Meet us at the FIGON Dutch Medicine Days

PneumoNP partners will attend FIGON Dutch Medicine Days in Ede, the Netherlands on 2nd and 3rd of October 2017. ...
Read More

New publication: Experimental methods for aerosol measurements in human airways

Experimental methods for flow and aerosol measurements in human airways and their replicas

Abstract

Recent developments in the prediction of local aerosol deposition in human lungs are driven by the fast development of computational simulations. Although such simulations provide results in unbeatable resolution, significant differences among distinct methods of calculation emphasize the need for highly precise experimental data in order to specify boundary conditions and for validation purposes.

This paper reviews and critically evaluates available methods for the measurement of single and disperse two-phase flows for the study of respiratory airflow and deposition of inhaled particles, performed both in vivo and in replicas of airways. Limitations and possibilities associated with the experimental methods are discussed and aspects of the computational calculations that can be validated are indicated.

Graphical abstract

The review classifies the methods into following categories:

  1. point-wise and planar methods for velocimetry in the airways,
  2. classic methods for the measurement of the regional distribution of inhaled particles,
  3. standard medical imaging methods applicable to the measurement of the regional aerosol distribution and
  4. emerging and nonconventional methods.

All methods are described, applications in human airways studies are illustrated, and recommendations for the most useful applications of each method are given.

Authors

Frantisek Lizal, Jan Jedelsky, Kaye Morgan, Katrin Bauer, Jordi Llop, Unai Cossio, Stavros Kassinos, Sylvia Verbanck, Jesús Ruiz-Cabello, Arnoldo Santos, Edmund Koch, Christian Schnabel

Source

Lizal, F., Jedelsky, J., Morgan, K., Bauer, K., Llop, J., Cossio, U., … & Koch, E. (2017). Experimental methods for flow and aerosol measurements in human airways and their replicas. European Journal of Pharmaceutical Sciences.

__________________________________________________________________

Read more PneumoNP news

cropped-Logo_PneumoNP_Simple_PRINT-01.png

Join the Molecular Imaging Workshop 2017

The second edition of the Molecular Imaging Workshop 2017 (MIW2017) will be held from 20th to 23rd November 2017 in San Sebastian, ...
Read More
ETP Nanomedicine is the European Forum aiming at developping, supporting and promoting the field of nanotechnologies applied to medicine.
ETP Nanomedicine translates business, clinical interface, toxicology and characterisation, education and training, ethics and social impact to pursue its goal. Indeed, the organisation intent is to enable diagnostics and imaging, therapy and targeted delivery, and regenerative medicine.

Meet us at the ETPN2017 event

PneumoNP partners will attend the ETPNanomedicine event in Malaga, Spain from 17th to 19th October 2017. The European Technology Platform on ...
Read More
FIGON Conference

Meet us at the FIGON Dutch Medicine Days

PneumoNP partners will attend FIGON Dutch Medicine Days in Ede, the Netherlands on 2nd and 3rd of October 2017. ...
Read More

Meet us at EuroNanoForum 2017

Iraida Loinaz, coordinator of the PneunoNP project, attends the EuroNanoForum 2017 conference.

EuroNanoForum 2017 is an international event that focus on how nano and materials technologies can strengthen competitiveness across all European industries. The event takes place in Malta from 21th and 23th June 2017.

Nanotechnology is expected to gain importance in the near future in many industries. For example, nanomedicine could solve numerous healthcare challenges especially in the field of drug-delivery. However, from the pharmaceutical point of view, there is insufficient clinical data that allows the assessment of the role of nanotechnology in the potential of these products.

It is time to push those promising developments to the clinical stage. Iraida Loinaz’s talk will show real examples on how is possible to translate a lab scale protocol, into a robust GMP manufacturing process, and those key aspects to take into account to reduce the time of development.


Iraida Loinaz, coordinator of PneunoNP project, is the Health business development Manager of IK4-Cidetec. In the last years Dr. Loinaz’s group has been specialized in translational research. They are establishing a pilot plant operating under GMP for the production of nanopharmaceuticals.

“It is my first time attending EuroNanoForum,” Dr Loinaz said. “I really look forward to meeting main stakeholders in the field of nanotechnologies for health and share our experiences in the field.”

Find all the necessary information related to the event on: www.eccmid.org.

EuroNanoForum 2017 logo

__________________________________________________________________
Follow the PneumoNP team from event to event
cropped-Logo_PneumoNP_Simple_PRINT-01.png

Join the Molecular Imaging Workshop 2017

The second edition of the Molecular Imaging Workshop 2017 (MIW2017) will be held from 20th to 23rd November 2017 in San Sebastian, ...
Read More
ETP Nanomedicine is the European Forum aiming at developping, supporting and promoting the field of nanotechnologies applied to medicine.
ETP Nanomedicine translates business, clinical interface, toxicology and characterisation, education and training, ethics and social impact to pursue its goal. Indeed, the organisation intent is to enable diagnostics and imaging, therapy and targeted delivery, and regenerative medicine.

Meet us at the ETPN2017 event

PneumoNP partners will attend the ETPNanomedicine event in Malaga, Spain from 17th to 19th October 2017. The European Technology Platform on Nanomedicine ...
Read More
FIGON Conference

Meet us at the FIGON Dutch Medicine Days

PneumoNP partners will attend FIGON Dutch Medicine Days in Ede, the Netherlands on 2nd and 3rd of October 2017. The ...
Read More

Confront antibiotic resistance with a better diagnostic system

To slow down the rise of non-curable infections, a Dutch company developed a diagnostic kit to identify strains of antibiotic-resistant bacteria.

medic-563425_960_720

The World Health Organization (WHO) warns citizens for several years now: many antibiotics are becoming useless to heal bacterial infections. Indeed, bacteria develop new defence mechanisms to resist the action of antibiotics. By accurate detection of these resistance mechanisms, prescription of useless antibiotics can be avoided. Instead, an appropriate antibiotic treatment can be prescribed to cure the patient.

A precise diagnosis contributes also to avoid the spread of resistant bacteria and the rise of new resistance mechanisms. Supposing all infections were treated with personalized antibiotic treatments, bacteria would have less room to evolve or to spread.

To tackle these challenges, the Dutch company PathoFinder strives to provide an on-time delivery and dependable diagnostic system. The kit will allows to identifying antibiotic resistant strains of bacteria from a unique sample. This new kit addresses the need of hospitals, where time and precision are valuable.

@PathoFinder, 2017

@PathoFinder, 2017

The kit, a PCR multiplex, can identify over 25 of the most important resistance gene families, namely carbapenemases, extended-spectrum beta-lactamases (ESBL), plasmid-mediated cephalosporinases (pAmpC) and plasmid-mediated colistin resistance genes.

PathoFinder, accredited of the ISO 13485, benefits from a long experience in medical devices’ design. This time, the team innovates with a multiplex that runs on standard laboratory equipments. About 3 years and a half were needed for the multiplex to be conceived. Later in 2017, the multiplex will enter clinical validation. It will need a few more official certifications before entering the market.

The company PathoFinder was supported by a European consortium of academic and private research groups. Indeed, the Dutch company participates to the PneumoNP project. The rapid development of the multiplex would not be possible without the contribution of their partners. Together they engage against the rise of antibiotic resistance. In this framework, PathoFinder contributes by improving usage of antibiotics with the development of the diagnostic kit.

__________________________________________________________________

Read more PneumoNP news

cropped-Logo_PneumoNP_Simple_PRINT-01.png

Join the Molecular Imaging Workshop 2017

The second edition of the Molecular Imaging Workshop 2017 (MIW2017) will be held from 20th to 23rd November 2017 in San Sebastian, ...
Read More
ETP Nanomedicine is the European Forum aiming at developping, supporting and promoting the field of nanotechnologies applied to medicine.
ETP Nanomedicine translates business, clinical interface, toxicology and characterisation, education and training, ethics and social impact to pursue its goal. Indeed, the organisation intent is to enable diagnostics and imaging, therapy and targeted delivery, and regenerative medicine.

Meet us at the ETPN2017 event

PneumoNP partners will attend the ETPNanomedicine event in Malaga, Spain from 17th to 19th October 2017. The European Technology Platform on ...
Read More
FIGON Conference

Meet us at the FIGON Dutch Medicine Days

PneumoNP partners will attend FIGON Dutch Medicine Days in Ede, the Netherlands on 2nd and 3rd of October 2017. ...
Read More

New publication: Into the killing activity of an antimicrobial peptide against antibiotic-resistant K. pneumoniae

Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa

Abstracts

SET-M33 is a multimeric antimicrobial peptide active against Gram-negative bacteria in vitro and in vivo. Insights into its killing mechanism could elucidate correlations with selectivity.

Grpahical abstract of the publication: Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa

SET-M33 showed concentration-dependent bactericidal activity against colistin-susceptible and resistant isolates of P. aeruginosa and K. pneumoniae. Scanning and transmission microscopy studies showed that SET-M33 generated cell blisters, blebs, membrane stacks and deep craters in K. pneumoniae and P. aeruginosa cells. NMR analysis and CD spectra in the presence of sodium dodecyl sulfate micelles showed a transition from an unstructured state to a stable α-helix, driving the peptide to arrange itself on the surface of micelles.

SET-M33 kills Gram-negative bacteria after an initial interaction with bacterial LPS. The molecule becomes then embedded in the outer membrane surface, thereby impairing cell function. This activity of SET-M33, in contrast to other similar antimicrobial peptides such as colistin, does not generate resistant mutants after 24 h of exposure, non-specific interactions or toxicity against eukaryotic cell membranes, suggesting that SET-M33 is a promising new option for the treatment of Gram-negative antibiotic-resistant infections.

Authors

Hessel van der Weide, Jlenia Brunetti, Alessandro Pini, Luisa Bracci, Chiara Ambrosini, Pietro Lupetti, Eugenio Paccagnini, Mariangela Gentile, Andrea Bernini, Neri Niccolai, Denise Vermeulen-de Jongh, Irma A.J.M. Bakker-Woudenberg, Wil H.F. Goessens, John P. Hays, Chiara Falciani

Sources

H. van der Weide et al. Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa. Biochimica et Biophysica Acta (BBA) – Biomembranes, 2017. DOI: 10.1016/j.bbamem.2017.06.001.

__________________________________________________________________

Read more PneumoNP news

cropped-Logo_PneumoNP_Simple_PRINT-01.png

Join the Molecular Imaging Workshop 2017

The second edition of the Molecular Imaging Workshop 2017 (MIW2017) will be held from 20th to 23rd November 2017 in San Sebastian, ...
Read More
ETP Nanomedicine is the European Forum aiming at developping, supporting and promoting the field of nanotechnologies applied to medicine.
ETP Nanomedicine translates business, clinical interface, toxicology and characterisation, education and training, ethics and social impact to pursue its goal. Indeed, the organisation intent is to enable diagnostics and imaging, therapy and targeted delivery, and regenerative medicine.

Meet us at the ETPN2017 event

PneumoNP partners will attend the ETPNanomedicine event in Malaga, Spain from 17th to 19th October 2017. The European Technology Platform on ...
Read More
FIGON Conference

Meet us at the FIGON Dutch Medicine Days

PneumoNP partners will attend FIGON Dutch Medicine Days in Ede, the Netherlands on 2nd and 3rd of October 2017. ...
Read More

Call for abstracts for the Molecular Imaging Workshop 2017

The second edition of the Molecular Imaging Workshop 2017 (MIW2017) will be held from 20th to 23rd November 2017 in San Sebastian, Spain. Abstract submission is open until the 31st August 2017.

MIW 2017

Academic and industrial researchers are welcome to join the workshop. For instance an industrial forum is organized to exchange ideas and network. People can also submit abstracts to participate to the poster session.

Organized by CIC biomaGUNE, the workshop will cover topics related to molecular imaging. The MIW2017 is the opportunity to discuss molecular imaging applications to neurosciences and oncology. Do not miss the sessions dedicated to cardiovascular application, infection tracking and pneumology.

The PneumoNP project will also attend the event. Attendees will be updated of the latest results of the project.

Several invited speakers are already announced. Jesús Ruíz Cabello from the Complutense University of Madrid, Spain, will give a lecture on the “characterization of metabolic reprogramming in pulmonary hypertension”. Jason Holland will come from Zurich to discuss “PET radiotracers for imaging oncogenic signaling pathways”.
The full list of invited speakers is available on the MIW2017 website.

You can already submit your abstract for the MIW2017 and so until the 31st August 2017. All abstracts must be related to one of the following categories:

  • Oncology
  • Cardiology
  • Neurosciences
  • Infectious diseases and metabolism
  • Imaging technology, methodology and data analysis
  • Imaging probes
  • Pulmonology and respiratory

Changes in the application are accepted until the submission deadline. So, do not wait and submit your abstract on the MIW2017 website.

__________________________________________________________________
Follow the PneumoNP team from event to event
cropped-Logo_PneumoNP_Simple_PRINT-01.png

Join the Molecular Imaging Workshop 2017

The second edition of the Molecular Imaging Workshop 2017 (MIW2017) will be held from 20th to 23rd November 2017 in San Sebastian, ...
Read More
ETP Nanomedicine is the European Forum aiming at developping, supporting and promoting the field of nanotechnologies applied to medicine.
ETP Nanomedicine translates business, clinical interface, toxicology and characterisation, education and training, ethics and social impact to pursue its goal. Indeed, the organisation intent is to enable diagnostics and imaging, therapy and targeted delivery, and regenerative medicine.

Meet us at the ETPN2017 event

PneumoNP partners will attend the ETPNanomedicine event in Malaga, Spain from 17th to 19th October 2017. The European Technology Platform on Nanomedicine ...
Read More
FIGON Conference

Meet us at the FIGON Dutch Medicine Days

PneumoNP partners will attend FIGON Dutch Medicine Days in Ede, the Netherlands on 2nd and 3rd of October 2017. The ...
Read More

New publication: Synergistic activity profile of M33 against MDR strains of Gram-negative bacteria

Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens

Abstract

Infection sustained by multidrug-resistant and extensively drug-resistant bacterial pathogens is often untreatable with the standard of care antibiotics, and the combination of anti-infective compounds often represents the only therapeutic strategy to face this major clinical treat. SET-M33 is a novel antimicrobial peptide (AMP) that has demonstrated in vitro and in vivo antimicrobial activity against Gram-negative bacteria and has shown interesting features in preclinical evaluation. Particularly, it showed efficacy against a number of multidrug-resistant and extensively drug-resistant clinical strains of Gram-negative pathogens, in in vitro and in vivo assessments.

Visual abstract of M33SET-M33 showed synergistic activity with antibiotics of different families against these clinically relevant strains. A synergistic effect was observed for SET-M33 in combination with rifampin, meropenem, aztreonam, and tobramycin mostly on K. pneumoniae and A. baumannii strains, while the SET-M33 plus ciprofloxacin combination was additive with all tested strains. Synergy was not apparently linked to the bacterial species or phenotype but was rather strain-specific, highlighting the need for individual strain testing for synergistic antimicrobial combinations.

These findings extend current knowledge on synergistic activity of AMPs in combination with conventional agents and support the potential role of SET-M33 as a novel therapeutic agent against antibiotic-resistant Gram-negative pathogens.

Authors

Simona Pollini, Jlenia Brunetti, Samanta Sennati, Gian Maria Rossolini, Luisa Bracci, Alessandro Pini, Chiara Falciani

Source

S. Pollini et al. (2017). Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens. Journal of Peptide Science.

__________________________________________________________________

Read more PneumoNP news

cropped-Logo_PneumoNP_Simple_PRINT-01.png

Join the Molecular Imaging Workshop 2017

The second edition of the Molecular Imaging Workshop 2017 (MIW2017) will be held from 20th to 23rd November 2017 in San Sebastian, ...
Read More
ETP Nanomedicine is the European Forum aiming at developping, supporting and promoting the field of nanotechnologies applied to medicine.
ETP Nanomedicine translates business, clinical interface, toxicology and characterisation, education and training, ethics and social impact to pursue its goal. Indeed, the organisation intent is to enable diagnostics and imaging, therapy and targeted delivery, and regenerative medicine.

Meet us at the ETPN2017 event

PneumoNP partners will attend the ETPNanomedicine event in Malaga, Spain from 17th to 19th October 2017. The European Technology Platform on ...
Read More
FIGON Conference

Meet us at the FIGON Dutch Medicine Days

PneumoNP partners will attend FIGON Dutch Medicine Days in Ede, the Netherlands on 2nd and 3rd of October 2017. ...
Read More